Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Appl Microbiol ; 104(6): 1726-31, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18179539

ABSTRACT

AIMS: To assess whether conventional and organic dairy management practices are associated with differences in the susceptibility of Staphylococcus to antimicrobial agents. METHODS AND RESULTS: Staphylococcus was isolated from milk samples collected from conventional and organic dairies in west-central Minnesota. Isolates were categorized as (1) coagulase-positive, (2) novobiocin-sensitive coagulase-negative or (3) novobiocin-resistant coagulase-negative. Novobiocin-resistant coagulase-negative Staphylococcus (CNS) was more common on conventional farms and novobiocin-sensitive CNS predominated the isolates from organic farms. Overall, a larger proportion of isolates from organic rather than conventional farms were susceptible to erythromycin, pirlimycin and tetracycline. However, for pirlimycin and tetracycline, different patterns of susceptibility were observed among Staphylococcus categories. CONCLUSION: In this study, organic dairy management was associated with more overall antimicrobial susceptibility among Staphylococcus than was conventional management. However, different patterns of susceptibility among Staphylococcus categories suggest that multiple management practices, including some unrelated to antimicrobial use, may contribute to the observed differences in susceptibility. SIGNIFICANCE AND IMPACT OF THE STUDY: This study adds to our understanding of the implications of dairy management choices.


Subject(s)
Cattle Diseases/microbiology , Dairying , Food, Organic , Industrial Microbiology , Staphylococcal Infections/veterinary , Staphylococcus/isolation & purification , Animal Husbandry/methods , Animals , Anti-Infective Agents/pharmacology , Bacteriological Techniques , Cattle , Colony Count, Microbial/veterinary , Female , Microbial Sensitivity Tests , Milk/microbiology , Minnesota , Staphylococcus/classification , Staphylococcus/drug effects
3.
J Biol Chem ; 274(38): 27047-55, 1999 Sep 17.
Article in English | MEDLINE | ID: mdl-10480918

ABSTRACT

UDP-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (LpxA) catalyzes the reversible transfer of an R-3-hydroxyacyl chain from R-3-hydroxyacyl-acyl carrier protein to the glucosamine 3-OH of UDP-GlcNAc in the first step of lipid A biosynthesis. Lipid A is required for the growth and virulence of most Gram-negative bacteria, making its biosynthetic enzymes intriguing targets for the development of new antibacterial agents. LpxA is a member of a large family of left-handed beta-helical proteins, many of which are acyl- or acetyltransferases. We now demonstrate that histidine-, lysine-, and arginine-specific reagents effectively inhibit LpxA of Escherichia coli, whereas serine- and cysteine-specific reagents do not. Using this information in conjunction with multiple sequence alignments, we constructed site-directed alanine substitution mutations of conserved histidine, lysine, and arginine residues. Many of these mutant LpxA enzymes show severely decreased specific activities under standard assay conditions. The decrease in activity corresponds to decreased k(cat)/K(m,UDP-GlcNAc) values for all the mutants. With the exception of H125A, in which no activity is seen under any assay condition, the decrease in k(cat)/K(m,UDP-GlcNAc) mainly reflects an increased K(m,UDP-GlcNAc). His(125) of E. coli LpxA may therefore function as a catalytic residue, possibly as a general base. LpxA does not catalyze measurable UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc hydrolysis or UDP-GlcNAc/UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc exchange, arguing against a ping-pong mechanism with an acyl-enzyme intermediate.


Subject(s)
Acyltransferases/metabolism , Escherichia coli/enzymology , Histidine/metabolism , Acyltransferases/chemistry , Acyltransferases/genetics , Binding Sites , Catalysis , Cloning, Molecular , Histidine/chemistry , Kinetics , Lipid A/biosynthesis , Models, Chemical , Models, Molecular , Mutagenesis, Site-Directed
4.
J Biol Chem ; 273(49): 32369-72, 1998 Dec 04.
Article in English | MEDLINE | ID: mdl-9829962

ABSTRACT

UDP-GlcNAc acyltransferase (LpxA), the first enzyme of lipid A biosynthesis, catalyzes the transfer of an acyl chain activated on acyl carrier protein (ACP) to UDP-GlcNAc. LpxAs are very selective for the lengths of their acyl donor substrates. Escherichia coli LpxA prefers R-3-hydroxymyristoyl-ACP to R-3-hydroxydecanoyl-ACP by a factor of approximately 1000, whereas Pseudomonas aeruginosa LpxA prefers the opposite. E. coli G173M LpxA and the reciprocal P. aeruginosa M169G LpxA show reversed substrate selectivity in vitro and in vivo, demonstrating the existence of precise hydrocarbon rulers in LpxAs.


Subject(s)
Acyltransferases/chemistry , Hydrocarbons/chemistry , Acyltransferases/genetics , Amino Acid Sequence , Amino Acid Substitution , Binding Sites , Carbohydrate Sequence , Escherichia coli/genetics , Molecular Sequence Data , Protein Conformation , Sequence Homology, Amino Acid
5.
Trends Microbiol ; 6(4): 154-9, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9587193

ABSTRACT

Antibiotic-resistant bacterial infections are a major clinical problem. Lipid A, the active part of lipopolysaccharide endotoxins in Gram-negative bacteria, is an intriguing target for new antibacterial and anti-inflammatory agents. Inhibition of lipid A biosynthesis kills most Gram-negative bacteria, increases bacterial permeability to antibiotics and decreases endotoxin production.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Inflammatory Agents/pharmacology , Lipid A/antagonists & inhibitors , Animals , Carbohydrate Sequence , Gram-Negative Bacterial Infections/drug therapy , Humans , Lipid A/biosynthesis , Lipid A/physiology , Molecular Sequence Data , Sepsis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...